Dual-action ambroxol in treatment of chronic pain in Gaucher Disease

Chronic Pain

Children with Chronic Pain: Response Trajectories Following Intensive Pain Rehabilitation Treatment

J Pain.

Simons LE, Sieberg CB, Conroy C, Randall ET, Shulman J, Borsook D, Berde C, Sethna NF, Logan DE

doi: 10.1016/j.jpain.2017.10.005.

Chronic Pain

The Impact of Spatial Distribution of Pain on Long Term Trajectories for Chronic Pain Outcomes after Intensive Interdisciplinary Pain Treatment

Clin J Pain.

Williams SE, Homan KJ, Crowley SL, Pruitt DW, Collins AB, Deet ET, Samuel ND, John A, Banner K, Rose JB

doi: 10.1097/AJP.0000000000000793.

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain

Pain Ther.

Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Raffa RB, Bisney J

doi: 10.1007/s40122-018-0095-8.

Chronic Pain

Early Changes in Pain Acceptance Predict Pain Outcomes in Interdisciplinary Treatment for Chronic Pain

J Clin Med.

Probst T, Jank R, Dreyer N, Seel S, Wagner R, Hanshans K, Reyersbach R, Mühlberger A, Lahmann C, Pieh C

doi: 10.3390/jcm8091373.

COMMENTED

Chronic PainPain Relief

Internal health locus of control as a predictor of pain reduction in multidisciplinary inpatient treatment for chronic pain: a retrospective study

J Pain Res.

Zuercher-Huerlimann E, Stewart JA, Egloff N, von Känel R, Studer M, Grosse Holtforth M

doi: 10.2147/JPR.S189442.

Chronic Pain

Is It Worth It? A Comparison of an Intensive Interdisciplinary Pain Treatment and a Multimodal Treatment for Youth with Pain-related Disability

Clin J Pain.

Hurtubise K, Blais S, Noel M, Brousselle A, Dallaire F, Rasic N, Camden C

doi: 10.1097/AJP.

Chronic Pain

Changes in Pain and Psychosocial Functioning and Transition to Chronic Pain in Pediatric Sickle Cell Disease: A Cohort Follow-up Study

Clin J Pain.

Sil S, Cohen LL, Bakshi N, Watt A, Hathaway M, Abudulai F, Dampier C

doi: 10.1097/AJP.0000000000000827.

COMMENTED

Chronic Pain

Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies

Pain.

Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, Murnion B, Farrell M, Weier M, Degenhardt L

doi: 10.1097/j.pain.

Acute PainChronic PainPain Management

Dipyrone is the preferred nonopioid analgesic for the treatment of acute and chronic pain. A survey of clinical practice in German-speaking countries

Eur J Pain.

Reist L, Erlenwein J, Meissner W, Stammschulte T, Stüber F, Stamer UM

doi: 10.1002/ejp.1194.

Related content

Children with Chronic Pain: Response Trajectories Following Intensive Pain Rehabilitation Treatment

The Impact of Spatial Distribution of Pain on Long Term Trajectories for Chronic Pain Outcomes after Intensive Interdisciplinary Pain Treatment

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain

Early Changes in Pain Acceptance Predict Pain Outcomes in Interdisciplinary Treatment for Chronic Pain

Internal health locus of control as a predictor of pain reduction in multidisciplinary inpatient treatment for chronic pain: a retrospective study

Is It Worth It? A Comparison of an Intensive Interdisciplinary Pain Treatment and a Multimodal Treatment for Youth with Pain-related Disability

Changes in Pain and Psychosocial Functioning and Transition to Chronic Pain in Pediatric Sickle Cell Disease: A Cohort Follow-up Study

Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies

Dipyrone is the preferred nonopioid analgesic for the treatment of acute and chronic pain. A survey of clinical practice in German-speaking countries